Navigation Links
Favrille to Present at BIO InvestorForum
Date:10/2/2007

Live Webcast from the Palace Hotel in San Francisco on Wednesday, October

10th

SAN DIEGO, Oct. 2 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that Tamara Seymour, Chief Financial Officer, will present at the Biotechnology Industry Organization (BIO) InvestorForum at 10:15 a.m. Pacific time on Wednesday, October 10, 2007. The conference will be held at the Palace Hotel in San Francisco.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

Ms. Seymour will provide an overview of Favrille and the clinical trials of its lead compound, FavId(R), which is currently in a pivotal Phase 3 clinical trial for the treatment of follicular B-cell non-Hodgkin's lymphoma (NHL). A live webcast of the presentation can be accessed at http://www.favrille.com. The replay will be available approximately one hour after the presentation and will be archived until November 10, 2007.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.


'/>"/>
SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, its ... 280 nm wavelength range. This series joins Marktech’s current ... to 405nm. These new devices are suitable for applications ... Mark Campito, Marktech’s CEO states that “what makes this ... that we offer it in one of the largest ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black Box ... a three phase process that can lead to the ... would go far beyond anything previously imagined. First everyone ... healthcare.” , “Every effort to improve the quality of ... progress throughout that system because all of the experts ...
(Date:9/23/2014)... September 23, 2014 Healthcare ... globe will convene at the Society for ... be held October 26-28 in Houston, Texas ... and practice in individualized integrative cancer care. ... nurses, psychologists, nutritionists, naturopaths, acupuncturists, and other ...
(Date:9/23/2014)... Plymouth, MN (PRWEB) September 23, 2014 ... named NimbeLink, a developer of cellular modems ... a finalist in the Startup category for the ... will be held at the Minneapolis Convention Center ... Minnesota companies and individuals who have shown superior ...
Breaking Biology Technology:Marktech Introduces its New Line of Deep UV Emitters 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3
... KONG, China , July 19 /PRNewswire/ - Aegera Therapeutics ... of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, ... (primary liver cancer). , , ... This study, entitled "A Phase 1-2, Open-Label Study of The ...
... announces that a new market research report is available in its catalogue: , ... Cells Market And Applications. 2009-2015 , , , ... , , REPORT ... The ,Stem Cells Market and Applications: (2009-2015), reviews the latest Stem Cells ...
... PARK, N.C. , July 16 Talecris Biotherapeutics Holdings Corp. (Nasdaq: ... on July 29, 2010 . Due to the pending merger with Grifols, S.A., ... , , , ... Dedication. Innovation. , , , ...
Cached Biology Technology:Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 2Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 2Reportlinker Adds Stem Cells Market And Applications. 2009-2015 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 4Reportlinker Adds Stem Cells Market And Applications. 2009-2015 5Reportlinker Adds Stem Cells Market And Applications. 2009-2015 6Reportlinker Adds Stem Cells Market And Applications. 2009-2015 7Reportlinker Adds Stem Cells Market And Applications. 2009-2015 8Reportlinker Adds Stem Cells Market And Applications. 2009-2015 9Reportlinker Adds Stem Cells Market And Applications. 2009-2015 10Reportlinker Adds Stem Cells Market And Applications. 2009-2015 11Reportlinker Adds Stem Cells Market And Applications. 2009-2015 12Reportlinker Adds Stem Cells Market And Applications. 2009-2015 13Reportlinker Adds Stem Cells Market And Applications. 2009-2015 14Reportlinker Adds Stem Cells Market And Applications. 2009-2015 15Reportlinker Adds Stem Cells Market And Applications. 2009-2015 16Reportlinker Adds Stem Cells Market And Applications. 2009-2015 17Reportlinker Adds Stem Cells Market And Applications. 2009-2015 18Reportlinker Adds Stem Cells Market And Applications. 2009-2015 19Reportlinker Adds Stem Cells Market And Applications. 2009-2015 20Reportlinker Adds Stem Cells Market And Applications. 2009-2015 21Reportlinker Adds Stem Cells Market And Applications. 2009-2015 22Reportlinker Adds Stem Cells Market And Applications. 2009-2015 23Reportlinker Adds Stem Cells Market And Applications. 2009-2015 24Reportlinker Adds Stem Cells Market And Applications. 2009-2015 25Reportlinker Adds Stem Cells Market And Applications. 2009-2015 26Reportlinker Adds Stem Cells Market And Applications. 2009-2015 27Reportlinker Adds Stem Cells Market And Applications. 2009-2015 28Reportlinker Adds Stem Cells Market And Applications. 2009-2015 29Reportlinker Adds Stem Cells Market And Applications. 2009-2015 30Reportlinker Adds Stem Cells Market And Applications. 2009-2015 31Reportlinker Adds Stem Cells Market And Applications. 2009-2015 32Reportlinker Adds Stem Cells Market And Applications. 2009-2015 33
(Date:9/21/2014)... are significantly less likely to report taking iron supplements ... children who are developing normally, a study by researchers ... Low iron intake was associated with a five-fold greater ... was 35 or older at the time of the ... such as obesity hypertension or diabetes. , The research ...
(Date:9/21/2014)... was previously thought, newborn immune T cells may have ... according to a new study led by King,s College ... that of adults, babies may still be able to ... in the journal Nature Medicine . , Our ... of immune cells, including neutrophils which play an important ...
(Date:9/19/2014)... biology professor will study the unique bioelectric signaling system ... benefit people,s health. The OU researcher is working ... to produce the signals used to map the world ... a rate of 500-600 discharges a second throughout their ... fish are extreme, but necessary for survival. , "There ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Immune system of newborn babies is stronger than previously thought 2
... 2009, the National Science Foundation (NSF) will host its ... This year,s forum focuses on ecological connectivity and ... In an ecological context, connectivity is defined as the ... and animals among interconnected locations. In this symposium, ...
... Seawater is a complex, dynamic mixture of ... scientists best efforts, presents difficulties in measuring its ... water itself, the calculations scientists employ to measure ... over the years as research techniques and instrumentation ...
... revolutionary new technology developed at The University of Nottingham ... far. Using a scientific technique known as Hydropyrolysis ... able to date chemical fossils discovered in sedimentary rocks ... fossil steroids, remnants of a type of sponge known ...
Cached Biology News:National Science Foundation forum to address ecological connectivity and climate in a changing world 2New equation of state of seawater 2New equation of state of seawater 3Engineering technology pinpoints earliest signs of animal life 2
... Camera hood with 5.6" TFT color screen, without ... system use digital camera with 8.0 mega pixel ... requirements and small budget. View image from large ... specific feature. It is suitable to capture image ...
... The binding specificity and signaling of the ... to be modified by alternative splicing--which has ... SpliceArrays you can perform a classical expression ... the different alternatively spliced forms of the ...
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... Apoptosis is an evolutionarily conserved form ... cellular process. The central component of ... enzymes called caspases. These enzymes participate ... triggered in response to pro-apoptotic signals and ...
Biology Products: